A national survey of 2,200 U.S. women found that middle-aged women reported the highest levels of problematic alcohol use but had the lowest awareness that alcohol consumption increases breast cancer risk.

In a new study, patients with 4 types of obesity-related cancer who were taking a GLP-1 medication were significantly less likely to see their cancer progress to stage 4.

In a new study, breast cancer patients using GLP-1 medications for obesity and/or diabetes had a lower risk of recurrence and death over 10 years of follow-up.

In a new study, breast cancer survivors who completed a three-month high-intensity resistance training program improved strength, mobility, balance, and muscle mass—supporting a faster return to everyday activities.

New research suggests breast cancer patients who choose to fight their disease with complementary or alternative therapies are nearly 4 times more likely to die within 5 years.

The number of new breast cancer cases worldwide is predicted to surpass 3.5 million by 2050. But researchers say targeting six lifestyle risk factors could help change the trajectory.

In a new study, women with very early-stage DCIS breast cancer taking tamoxifen alone had higher recurrence rates than researchers expected. But they say the incidence of invasive breast cancer was still low at 5 years, suggesting tamoxifen alone may be an option in “carefully selected patients.”

A new study finds acupuncture may help breast cancer survivors struggling with attention, memory and other cognitive problems.

A new study finds an increasing number of women 18-49 years old are being diagnosed with breast cancer, and most of the cases are invasive.

Major advances in treatment and care have led to improved survival for many women with advanced breast cancer, new study finds.

Researchers analyzed cancer trends in 42 countries and found a surge in certain cancer types in both young and older adults – with one exception.

A new report from the American Cancer Society finds a steep rise in lobular breast cancer between 2012 and 2021.

The risk of developing a second primary cancer after being treated for early invasive breast cancer is only slightly higher than the general population, according to a new study.

In a new pilot study, researchers found breast cancer patients who experienced cognitive impairment after chemotherapy had lower levels of gray matter in brain regions connected to memory and language.